Definitive Contract W81XWH20C0024
- Not listed
- This is a $1,070,532.90 firm fixed-price SBIR Phase II research and development contract awarded by the U.S. Army Medical Command (MEDCOM) to Keranetics Inc., a small business based in Winston-Salem, North Carolina. The contract is for the "Clinical Evaluation of Biocompatible Dressings for the Delivery of Analgesics" and was awarded under solicitation H2-0480. Keranetics is developing its KeraStat gel technology to prevent scar contracture after burn injuries. This SBIR Phase II...
- This is a $998,790.43 federal contract award from the U.S. Army Medical Command (MEDCOM) to Keranetics, LLC, a small business. The contract is a Small Business Innovation Research (SBIR) Phase II award, which typically funds further development of technologies previously explored in a Phase I effort. The contract is a definitive contract with a completion date of November 5, 2019. The contract was set aside for small businesses. No additional details about the specific product or service being...
- This $167,470.02 Phase I Small Business Innovation Research (SBIR) contract was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Kericure Inc., a small disadvantaged, woman-owned biotechnology company specializing in novel wound care products. The contract is for research and development efforts on a ruggedized, spray-on antimicrobial wound dressing for treatment of multiple sulfur mustard-induced dermal injuries in theater to mitigate...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,986,378 Definitive Contract to Synedgen, Inc., a small business prime contractor, to conduct Phase II Small Business Innovation Research (SBIR) efforts for the development of technologies to control scar formation after burn injuries. The contract is designated as a Total Small Business set-aside and has an ultimate completion date of April 1, 2023. Synedgen, a for-profit manufacturer with expertise in regenerative medicine...
- The National Cancer Institute (NCI) awarded a $196,707 firm fixed price Small Business Innovation Research (SBIR) Phase I contract to Synedgen, Inc., a for-profit manufacturer, to conduct research and development for biomedical basic research. The contract was designated as a Total Small Business set-aside. Through this SBIR Phase I award, Synedgen will advance scientific knowledge and technologies to control scar formation after burn injuries, leveraging its expertise in regenerative medicine...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Applied Tissue Technologies LLC, a for-profit limited liability company. The contract, valued at $420,308.75, is for the "Development of Technologies that Address the Complex Architecture of the Face during the Treatment of Severe Facial Burn Injury". This SBIR Phase II contract was awarded under the Major Program Code S10. The contract is a Definitive Contract with a...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Kerberos International, Inc., a self-certified small disadvantaged and women-owned small business. The $972,654.73 firm fixed-price contract will support Kerberos' STTR Phase II research and development efforts. Kerberos has extensive experience providing protective security officer services to federal agencies like the Department of Homeland...
- <p>This is a firm fixed-price contract awarded by the U.S. Army Medical Command (MEDCOM) to Nanoderm Sciences, Inc., a small business, for a SBIR (Small Business Innovation Research) Phase I project. The contract has a ceiling value of $149,837.83 and a completion date of April 27, 2016. The contract is for research and development under the SBIR program, but the specific details of the products or services being delivered are not provided in the information given.</p>
- The Department of the Army Medical Command awarded a Small Business Innovation Research (SBIR) Phase I contract to Karagozian & Case, Inc., a for-profit science and engineering consulting firm, for $249,966.17. The contract is for medical research and development, classified under the SBIR program. Karagozian & Case has previously performed work as both a prime contractor and subcontractor on various federal contracts, including providing services related to design, vulnerability...
- The U.S. Air Force Research Laboratory (AFRL) awarded a $1.25 million Phase II contract to Gelsana Therapeutics Inc., a woman-owned small business and HUBZone-certified firm, to develop novel zwitterionic hydrogels for enhanced wound healing in combat-related burn injuries. The contract, awarded on March 7, 2024, with completion targeted for October 2026, represents a firm fixed-price purchase order under the total small business set-aside program. This award follows Gelsana's Phase I SBIR...
The Department of the Army Medical Command awarded Keranetics Inc., doing business as Keranetics, a $699,139.77 firm fixed price contract to support research and development efforts under Phase II of the Small Business Innovation Research program. The contract aims to advance Keranetics' KeraStat(R) gel technology to prevent scar contracture after burn injuries, as proposed in their submission titled "KeraStat(R) Gel to Prevent Scar Contracture After Burn Injuries." The prime contractor will perform work in Winston-Salem, North Carolina over a three-year period ending in July 2023. The award is fully set aside for small businesses. The Department of the Army Medical Command supports the U.S. Army through medical research and healthcare initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Vendor DUNS or Name Change - Non-Novation | $0 | 11/12/21 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 12/1/20 | |
| Not listed | Not listed | $699.1k | 3/5/20 |